Magna-Poultice™

Magna-Poultice™

Drug Labeling and Warnings

Drug Details

k">

MAGNA POULTICE- magnesium sulfate poultice 
FIRST PRIORITY INCORPORATED

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Magna-Poultice

Decongestant Poultice.

For Strains, Sprains, and Bruises.


An Osmotic Agent for External Application.

For Animal Use Only
Keep Out of Reach of Children

INDICATIONS:

A poultice paste for use on horses and cattle.

DIRECTIONS FOR USE:

Apply locally as a poultice (without rubbing) to acute swellings, sprains, contusions, acute mastitis, swollen glands. May be repeated within 24 hours, as indicated.

CAUTION:

Avoid contact with eyes and mucous membranes.

image of eye clock

INGREDIENTS:

Magnesium Sulfate (epsom salt)...............60%
Methyl Salicylate ........................................ q.s.

In a water soluble base.

STORAGE:

Store at controlled room temperature between 15°-30°C (59°-86°F). Keep container closed when not in use.

Net Contents:

20 oz (567.0 g) Reorder No. TP205PC

10 lb (4.5 kg) Reorder No. TP206PC

Priority Care is a registered trademark of First Priority, Inc.

Made in U.S.A.

Manufactured By: FIRST PRIORITY, INC., Elgin, IL 60123

www.prioritycare.com

NOT RETURNABLE IF OUTDATED

Net Contents: 20 oz (567.0 g)

image of LBPCTP205_r1215

Net Contents: 10 lb (4.5 kg)

image of LBPCTP206_i0808

MAGNA POULTICE 
magnesium sulfate poultice
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC: 58829-312
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM SULFATE HEPTAHYDRATE (UNII: SK47B8698T) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM SULFATE HEPTAHYDRATE272627 mg  in 1 g
METHYL SALICYLATE (UNII: LAV5U5022Y) (SALICYLIC ACID - UNII:O414PZ4LPZ) METHYL SALICYLATE4540 mg  in 1 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 58829-312-2012 in 1 CASE
1567.0 g in 1 JAR
2NDC: 58829-312-074536 g in 1 PAIL
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/01/2008
Labeler - FIRST PRIORITY INCORPORATED (179925722)
Establishment
NameAddressID/FEIBusiness Operations
FIRST PRIORITY INCORPORATED179925722manufacture, label

Revised: 7/2019
 
FIRST PRIORITY INCORPORATED


© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.